Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program
- PMID: 27888680
- DOI: 10.1016/j.psychres.2016.11.007
Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program
Abstract
Substance use disorders (SUD) in first-episode psychosis (FEP) are highly prevalent and linked with poor outcomes. However, most longitudinal studies investigating their impacts in FEP have not reported proportions of patients who ceased SUD. Our aim was to examine the influence of SUD course on functional and symptomatic outcomes as well as service use in FEP. We performed a 2-year longitudinal study of 212 FEP patients, aged between 18 and 30 years, admitted to 2 early psychosis services in Montréal, Québec, Canada. We observed that cannabis was the first substance abused (42.9% at baseline), followed by alcohol (19.3%). The SUD rate decreased by approximately 30% during the first year. Patients with persistent SUD had worse functional outcomes (Quality of Life Scale, Social and Occupational Functioning Assessment Scale, employment), more symptoms (Positive and Negative Symptoms Scale) and heavier service use (emergency and hospitalization). SUD persistence was associated with illness severity, homelessness and cluster-B personality. Those living with their parents and financially supported by them were more likely to cease SUD. Our results indicate that SUD course was more significant than having SUD at admission; persistent SUD was associated with worse outcomes. SUD decreased during a general early psychosis intervention program (with no specialized SUD treatment). An integrated, specialized approach targeting FEP patients with predictive factors of SUD persistence during the first years of treatment might increase SUD cessation and possibly improve outcomes.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.Psychol Med. 2017 Oct;47(14):2461-2471. doi: 10.1017/S0033291717000976. Epub 2017 Apr 20. Psychol Med. 2017. PMID: 28424105
-
Specialized assertive community treatment intervention for homeless youth with first episode psychosis and substance use disorder: A 2-year follow-up study.Early Interv Psychiatry. 2020 Apr;14(2):203-210. doi: 10.1111/eip.12846. Epub 2019 Jul 5. Early Interv Psychiatry. 2020. PMID: 31274239 Clinical Trial.
-
Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder.Early Interv Psychiatry. 2020 Feb;14(1):69-79. doi: 10.1111/eip.12826. Epub 2019 May 24. Early Interv Psychiatry. 2020. PMID: 31125513
-
[First Episode Psychosis and Substance Use Disorder: Narrative Review of Best Practices and Adapted Approaches for Assessment and Monitoring].Sante Ment Que. 2021 Fall;46(2):277-306. Sante Ment Que. 2021. PMID: 35617502 Review. French.
-
[What support of young presenting a first psychotic episode, when schooling is being challenged?].Encephale. 2017 Dec;43(6):570-576. doi: 10.1016/j.encep.2017.10.001. Epub 2017 Nov 8. Encephale. 2017. PMID: 29128195 Review. French.
Cited by
-
Remission with or without comorbid substance use disorders in early psychosis: long-term outcome in integrated care (ACCESS III study).Front Psychol. 2023 Dec 21;14:1237718. doi: 10.3389/fpsyg.2023.1237718. eCollection 2023. Front Psychol. 2023. PMID: 38187418 Free PMC article.
-
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial.JMIR Res Protoc. 2023 Dec 18;12:e53094. doi: 10.2196/53094. JMIR Res Protoc. 2023. PMID: 38109196 Free PMC article.
-
A multiple baseline trial of adapted prolonged exposure psychotherapy for individuals with early phase psychosis, comorbid substance misuse, and a history of adversity: A study protocol.Front Psychol. 2022 Dec 12;13:1012776. doi: 10.3389/fpsyg.2022.1012776. eCollection 2022. Front Psychol. 2022. PMID: 36578677 Free PMC article.
-
Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report.Int J Environ Res Public Health. 2022 Nov 30;19(23):16057. doi: 10.3390/ijerph192316057. Int J Environ Res Public Health. 2022. PMID: 36498129 Free PMC article.
-
A Scoping and Systematic Review of Employment Processes and Outcomes for Young Adults Experiencing Psychosis.Community Ment Health J. 2023 May;59(4):728-755. doi: 10.1007/s10597-022-01056-z. Epub 2022 Dec 4. Community Ment Health J. 2023. PMID: 36463531
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
